Aerovate Therapeutics, Inc.
Total Trades
168
Buys
1
Sells
87
Largest Trade
$1M+
Insiders
8
Institutional Funds
10
Inst. Value
$1M+
Activist Filings
18
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| NIVEN RALPH | CHIEF SCIENTIFIC O… | EXERCISE | $1K–$15K | 2K | $2.02 | Oct 7, 2022 |
| NIVEN RALPH | CHIEF SCIENTIFIC O… | SELL | $15K–$50K | 2K | $15.75 | Oct 7, 2022 |
| Dake Benjamin T | SEE REMARKS | SELL | $100K–$500K | 8K | $17.33 | Sep 14, 2022 |
| Dake Benjamin T | SEE REMARKS | EXERCISE | $15K–$50K | 8K | $2.14 | Sep 14, 2022 |
| Dake Benjamin T | See Remarks | EXERCISE | $15K–$50K | 8K | $1.97 | Sep 12, 2022 |
| Dake Benjamin T | See Remarks | SELL | $100K–$500K | 8K | $17.80 | Sep 12, 2022 |
| Dake Benjamin T | See Remarks | SELL | $100K–$500K | 13K | $18.50 | Sep 8, 2022 |
| Dake Benjamin T | See Remarks | EXERCISE | $15K–$50K | 17K | $1.74 | Sep 8, 2022 |
| NIVEN RALPH | Chief Scientific O… | EXERCISE | $1K–$15K | 2K | $2.02 | Sep 7, 2022 |
| NIVEN RALPH | Chief Scientific O… | SELL | $15K–$50K | 2K | $19.00 | Sep 7, 2022 |
| NIVEN RALPH | Chief Scientific O… | SELL | $15K–$50K | 2K | $21.18 | Aug 19, 2022 |
| NIVEN RALPH | Chief Scientific O… | EXERCISE | $1K–$15K | 2K | $2.02 | Aug 19, 2022 |
| Dake Benjamin T | See Remarks | SELL | $100K–$500K | 21K | $23.00 | Aug 18, 2022 |
| Dake Benjamin T | See Remarks | EXERCISE | $15K–$50K | 21K | $1.74 | Aug 18, 2022 |
| Dake Benjamin T | See Remarks | SELL | $100K–$500K | 14K | $24.07 | Aug 12, 2022 |
| Dake Benjamin T | See Remarks | EXERCISE | $15K–$50K | 14K | $1.74 | Aug 12, 2022 |
| Dake Benjamin T | See Remarks | EXERCISE | $15K–$50K | 16K | $1.74 | Aug 10, 2022 |
| Dake Benjamin T | See Remarks | SELL | $100K–$500K | 16K | $24.31 | Aug 10, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 10 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 362K | $500K+ | SH |
| BlackRock, Inc. | 36K | $50K–$100K | SH |
| RHUMBLINE ADVISERS | 23K | $50K–$100K | SH |
| Bank of New York Mellon Corp | 5K | $1K–$15K | SH |
| NEW YORK STATE COMMON RETIREMENT FUND | 4K | $1K–$15K | SH |
| CWM, LLC | 2K | $1K–$15K | SH |
| NISA INVESTMENT ADVISORS, LLC | 868 | $1K–$15K | SH |
| AMALGAMATED BANK | 347 | $1K–$15K | SH |
| ROTHSCHILD INVESTMENT LLC | 230 | <$1K | SH |
| Capital Advisors, Ltd. LLC | 8 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2024
2.2%
629K shares
SC 13D/A · Jun 20, 2024
32.0%
9.2M shares
SC 13D/A · Apr 30, 2024
28.9%
8.3M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 21, 2024
9.0%
3.8M shares
SC 13G/A · Feb 14, 2024
0.0%
6 shares
SC 13G/A · Feb 14, 2024
6.1%
1.7M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13D/A · Jun 27, 2023
30.0%
8.3M shares
SC 13G/A · Feb 14, 2023
8.0%
2.0M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2023
3.0%
745K shares
SC 13G/A · Feb 14, 2023
6.4%
6 shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 4, 2023
15.3%
3.8M shares
SC 13D/A · Dec 15, 2022
8.2%
2.0M shares
SC 13D/A · Jul 20, 2022
9.5%
2.3M shares
SC 13D/A · May 5, 2022
10.8%
2.6M shares
SC 13G · Feb 14, 2022
7.5%
1.8M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
2.5%
619K shares
SC 13G/A · Feb 14, 2022
6.5%
6 shares